Over Allegations In Expired Rice Controversy
The Food and Drugs Authority (FDA) of Ghana has expressed its willingness to undergo audits by local and international entities following allegations of negligence in the extension of the best-before dates for over 22,000 bags of rice distributed to Senior High Schools (SHS).
The controversy stems from claims that the FDA failed to perform adequate due diligence before approving the extension of the rice’s shelf life, prompting public scrutiny and calls for accountability.
However, Dr. Delese Mimi Darko, CEO of the FDA, defended the agency’s actions, emphasizing adherence to global regulatory standards.
“All approvals granted were based on strict compliance with international best practices, including rigorous testing and compliance with storage requirements,” Dr. Darko stated at a news conference.
She further assured that the FDA’s decisions align with protocols for managing use-by and best-before dates, as practised by regulatory authorities worldwide.
Dr. Darko reaffirmed the safety of the rice, noting that extensive testing and validation were conducted. Certifications from organizations such as PPRSD, CSIR-FRI, and India-based agencies confirmed the product’s wholesomeness before its release.
In response to criticisms, including calls for the resignation of top FDA officials, the agency reiterated its commitment to transparency and public health. “We are steadfast in ensuring food safety and protecting public health,” Dr. Darko affirmed.
The FDA also clarified that Lamens Investments Africa Limited, the rice importer, was fined GH¢100,000 for regulatory violations unrelated to the quality of the rice, further addressing misconceptions surrounding the incident.
